According to the results, LN, HA, occludin and ZO‐1 protein expression dramatically reduced after injection of miR‐200 inhibitor in NAFLD mice (Figure 2F, P < .05). The gene discussed is OCLN; the disease is metabolic dysfunction-associated steatotic liver disease.